SJ Medical
The global market for Endovascular Grafts is undergoing a transformative phase, driven by the increasing prevalence of abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA). As the world's population ages, the demand for minimally invasive alternatives to traditional open-heart surgery has surged. Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aneurysm Repair (TEVAR) have become the gold standards in modern vascular medicine.
Industry reports suggest that the interventional radiology and vascular surgery sectors are focusing heavily on precision delivery systems and biocompatible materials. The shift towards "patient-specific" medicine is fostering the development of fenestrated and branched grafts, which allow for the treatment of complex anatomies while preserving vital organ blood flow. Leading factories in China are now at the forefront of this evolution, matching global quality standards with competitive manufacturing scales.
Healthcare providers in Europe, North America, and emerging markets are seeking reliable suppliers who can offer CE-marked devices that balance high clinical efficacy with cost-efficiency. There is a growing need for vertically integrated manufacturing where the graft, delivery system, and auxiliary tools (like sheaths and guide wires) are produced under one quality management system.
Technological trends are leaning towards low-profile delivery systems (down to 12F or 14F) to minimize access-site complications. Additionally, the integration of AI-assisted pre-operative sizing and 3D-printed templates is revolutionizing how endovascular grafts are deployed in clinical settings.
Localized application involves tailoring device sizes to specific demographic anatomical traits. Chinese exporters are excelling by offering a wide range of French sizes (4F-8F) and customized catheter lengths, ensuring that clinicians in different regions—from urban specialized hospitals to regional diagnostic centers—have the right tools for every patient.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
Our facility is built in accordance with GMP standards, featuring a million-class clean workshop with localized hundred-class areas for critical assembly processes. This ensures the absolute sterility and particulate control required for implantable devices.
Equipped with state-of-the-art balloon forming machines, laser welding units, and automated inspection systems, we ensure every micron of our endovascular components meets rigorous engineering tolerances.
Led by senior engineers with decades of experience in the medical device industry, our R&D team continuously improves manufacturing processes to enhance product reliability and clinical performance.
SJ Medical strictly adheres to international quality standards. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval. These accolades demonstrate our commitment to safety and authority in the vascular intervention space.
As a leading Chinese exporter of vascular interventional devices, we offer several strategic advantages to our international partners:
Our global footprint extends to Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We don't just export products; we provide comprehensive clinical support and technical consultation to ensure successful patient outcomes across borders.
Choosing the right Endovascular Graft factory involves more than just price comparison. It requires an assessment of the manufacturer's R&D depth, their adherence to ISO 13485 standards, and their ability to provide comprehensive supporting accessories like Sheath Introducer Sets and Angiography Catheters. Hangzhou SJ Medical provides a one-stop solution, integrating diagnostic catheters with therapeutic balloon systems to ensure seamless procedural workflows.
Whether you are looking for 4F to 8F vascular sheaths or advanced PTCA guide wires, our portfolio is designed to meet the rigorous demands of modern cath labs. We invite global medical device distributors and hospital procurement offices to experience the reliability of SJ Medical—where Chinese manufacturing meets global innovation.